The prevention and treatment of COVID-19 in patients treated with hemodialysis.

Zeng, Binyu; Zhou, Jia; Peng, Daizhuang; Dong, Chengmei; Qin, Qun

Zeng, Binyu; Zhou, Jia; Peng, Daizhuang; Dong, Chengmei; Qin, Qun.

Afiliación

Zeng B; National Institution of Drug Clinical Trial, Xiangya Hospital, Central South University, Changsha, 410008, China.
Zhou J; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.
Peng D; International Science and Technology Innovation Cooperation Base for Early Clinical Trials of Biological Agents in Hunan Province, Changsha, China.
Dong C; National Institution of Drug Clinical Trial, Xiangya Hospital, Central South University, Changsha, 410008, China.
Qin Q; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.

Eur J Med Res ; 28(1): 410, 2023 Oct 09.

Article en En | MEDLINE | ID: mdl-37814329

Asunto(s)

COVID-19; Humanos; SARS-CoV-2; Vacunas contra la COVID-19/uso terapéutico; Factores de Riesgo; Diálisis Renal

Palabras clave

Anti-COVID-19 drug; COVID-19 vaccine; Efficacy; Hemodialysis; Safety

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Med Res Asunto de la revista: MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google